In Brief: U.S. Bioscience Ethyol
Executive Summary
U.S. Bioscience Ethyol: Crystalline dosage form of amifostine gains U.S. patent on Jan. 7 and FDA marketing clearance on Dec. 30. The new formulation is covered by a patent until July 31, 2012. Ethyol's composition of matter patent has expired...